JP2013544502A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544502A5
JP2013544502A5 JP2013532230A JP2013532230A JP2013544502A5 JP 2013544502 A5 JP2013544502 A5 JP 2013544502A5 JP 2013532230 A JP2013532230 A JP 2013532230A JP 2013532230 A JP2013532230 A JP 2013532230A JP 2013544502 A5 JP2013544502 A5 JP 2013544502A5
Authority
JP
Japan
Prior art keywords
cancer
otl
sample
methylation
survival
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013532230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544502A (ja
JP6010037B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/067660 external-priority patent/WO2012045888A1/en
Publication of JP2013544502A publication Critical patent/JP2013544502A/ja
Publication of JP2013544502A5 publication Critical patent/JP2013544502A5/ja
Application granted granted Critical
Publication of JP6010037B2 publication Critical patent/JP6010037B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013532230A 2010-10-08 2011-10-10 腫瘍浸潤全tリンパ球の分析に基づいて、がん患者の生存指標を測定する方法 Expired - Fee Related JP6010037B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10187046 2010-10-08
EP10187046.7 2010-10-08
PCT/EP2011/067660 WO2012045888A1 (en) 2010-10-08 2011-10-10 Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes

Publications (3)

Publication Number Publication Date
JP2013544502A JP2013544502A (ja) 2013-12-19
JP2013544502A5 true JP2013544502A5 (enExample) 2014-11-27
JP6010037B2 JP6010037B2 (ja) 2016-10-19

Family

ID=44802051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013532230A Expired - Fee Related JP6010037B2 (ja) 2010-10-08 2011-10-10 腫瘍浸潤全tリンパ球の分析に基づいて、がん患者の生存指標を測定する方法

Country Status (5)

Country Link
US (1) US20130260378A1 (enExample)
EP (1) EP2625288B1 (enExample)
JP (1) JP6010037B2 (enExample)
CA (1) CA2814150A1 (enExample)
WO (1) WO2012045888A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201221133D0 (en) 2012-11-23 2013-01-09 Epiontis Gmbh Epigenetic method for the identification of subpopulations of CD8 and T lympocytes, in particular CD8 alpha and beta T lymphocytes
GB201516971D0 (en) * 2015-09-25 2015-11-11 Epiontis Gmbh MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
GB201516972D0 (en) * 2015-09-25 2015-11-11 Epiontis Gmbh LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
DE102016005947B3 (de) * 2016-05-16 2017-06-08 Dimo Dietrich Verfahren zur Abschätzung der Prognose und zur Prädiktion des Ansprechens auf eine Immuntherapie von Patienten mit malignen Erkrankungen
US11685955B2 (en) 2016-05-16 2023-06-27 Dimo Dietrich Method for predicting response of patients with malignant diseases to immunotherapy
JP7061342B2 (ja) * 2018-03-14 2022-04-28 学校法人 愛知医科大学 エフェクター制御性t細胞の検出及び調製
DE102018116353B4 (de) * 2018-07-05 2020-06-10 Epiontis Gmbh Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening
WO2021077063A1 (en) * 2019-10-18 2021-04-22 Washington University Methods and systems for measuring cell states
WO2024254366A1 (en) 2023-06-09 2024-12-12 Dow Global Technologies Llc Method for producing corrugated laminated panels

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002171973A (ja) 2000-12-07 2002-06-18 Univ Tokyo Dnaメチル化パターンによる細胞の同定法
AU2003285586A1 (en) 2002-12-03 2004-06-23 Medical Research Council Regulatory t-cells
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
DK1826279T3 (da) 2006-02-28 2011-09-05 Charite Universitaetsmedizin Detektering og kvalitetskontrol af regulatoriske t-celler vha. DNA-metyleringsanalyse af FoxP3--genet
EP2141245A1 (en) * 2008-07-03 2010-01-06 Ivana Türbachova DNA methylation analysis of regulatory T cells through DNA-methylation analysis of the TSDR region of the gene foxP3
DK2199411T3 (en) * 2008-12-16 2015-08-03 Epiontis Gmbh Epigenetic markers for the identification of CD3-positive T lymphocytes

Similar Documents

Publication Publication Date Title
JP2013544502A5 (enExample)
Peng et al. Gastric microbiome alterations are associated with decreased CD8+ tissue-resident memory T cells in the tumor microenvironment of gastric cancer
Hurst et al. Microbiomes of urine and the prostate are linked to human prostate cancer risk groups
Mehra et al. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer
Wang et al. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
WO2011056489A3 (en) Diagnostic methods for determining prognosis of non-small cell lung cancer
Abdelrahman et al. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma
EP3524689A1 (en) Method for predicting the prognosis of breast cancer patient
EP2007874A2 (en) Propagation of primary cells
JP2012511917A5 (enExample)
Gimondi et al. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation
JP6010037B2 (ja) 腫瘍浸潤全tリンパ球の分析に基づいて、がん患者の生存指標を測定する方法
CN105018638A (zh) 胃癌发生相关分子标志物lncRNA HOTTIP的检测及应用
WO2013135454A1 (en) Epigenetic marker for the identification of cd3cd4 positive t lymphocytes
Leng et al. A direct plasma miRNA assay for early detection and histological classification of lung cancer
Kamies et al. Advances of single-cell genomics and epigenomics in human disease: where are we now?
Xu et al. Urinary cell-free DNA IQGAP3/BMP4 ratio as a prognostic marker for non–muscle-invasive bladder cancer
Türbachova et al. The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns
Giebel et al. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer
Peng et al. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
EP3473729A1 (en) Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method
AU2017254347B2 (en) Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor
Zhang et al. Identification of novel molecular therapeutic targets and their potential prognostic biomarkers based on cytolytic activity in skin cutaneous melanoma
JP6156621B2 (ja) Atllの診断のためのデータ取得方法、atll診断用キットおよびatll診断システム
Hu et al. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of non-small cell lung cancer